Please assess the completion status of the following clinical trial:

Trial Title: Intravenous Clarithromycin in Septic Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. written informed consent provided by first or second degree relatives;~2. intubation and mechanical ventilation at least 48 hours prior to enrolment; c) age of patients equal to or more than 18 years;~d) diagnosis of Ventilator Associated Pneumonia; and e) signs of sepsis~Exclusion Criteria:~1. neutropenia, defined as less than 500 neutrophils/mm3;~2. HIV infection;~3. oral intake of corticosteroids at a dose equal to or higher than 1mg/kg equivalent prednisone for a period greater than one month;~4. administration of drotrecogin alpha the last five days prior to enrolment; and e) atrioventricular block of second or third degree.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).